Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)

HKG:2563 Statistics

Total Valuation

HKG:2563 has a market cap or net worth of HKD 1.37 billion. The enterprise value is 798.65 million.

Market Cap	1.37B
Enterprise Value	798.65M

Important Dates

The next estimated earnings date is Thursday, May 28, 2026.

Earnings Date	May 28, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2563 has 364.59 million shares outstanding. The number of shares has increased by 2.79% in one year.

Current Share Class	216.72M
Shares Outstanding	364.59M
Shares Change (YoY)	+2.79%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.69%
Owned by Institutions (%)	12.51%
Float	113.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	23.37
PB Ratio	1.68
P/TBV Ratio	1.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.73
EV / Sales	13.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.93

Financial Position

The company has a current ratio of 9.78, with a Debt / Equity ratio of 0.00.

Current Ratio	9.78
Quick Ratio	8.69
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-3,581.71

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-18.60%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	447,764
Profits Per Employee	-1.06M
Employee Count	131
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-75.76%
50-Day Moving Average	3.47
200-Day Moving Average	7.51
Relative Strength Index (RSI)	53.58
Average Volume (20 Days)	38,910

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2563 had revenue of HKD 58.66 million and -139.45 million in losses. Loss per share was -0.39.

Revenue	58.66M
Gross Profit	50.96M
Operating Income	-160.92M
Pretax Income	-139.45M
Net Income	-139.45M
EBITDA	-150.56M
EBIT	-160.92M
Loss Per Share	-0.39

Balance Sheet

The company has 573.19 million in cash and 982,915 in debt, with a net cash position of 572.20 million or 1.57 per share.

Cash & Cash Equivalents	573.19M
Total Debt	982,915
Net Cash	572.20M
Net Cash Per Share	1.57
Equity (Book Value)	818.07M
Book Value Per Share	2.24
Working Capital	633.48M

Cash Flow

In the last 12 months, operating cash flow was -145.15 million and capital expenditures -16.94 million, giving a free cash flow of -162.09 million.

Operating Cash Flow	-145.15M
Capital Expenditures	-16.94M
Free Cash Flow	-162.09M
FCF Per Share	-0.44

Margins

Gross margin is 86.87%, with operating and profit margins of -274.33% and -237.73%.

Gross Margin	86.87%
Operating Margin	-274.33%
Pretax Margin	-237.73%
Profit Margin	-237.73%
EBITDA Margin	-256.67%
EBIT Margin	-274.33%
FCF Margin	n/a

Dividends & Yields

HKG:2563 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.79%
Shareholder Yield	-2.79%
Earnings Yield	-10.17%
FCF Yield	-11.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2563 has an Altman Z-Score of 36.73 and a Piotroski F-Score of 1.

Altman Z-Score	36.73
Piotroski F-Score	1